Diurnal Group PLC | Balance Sheet

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
563.00
951.00
6,073.00
30,114.00
19,881.00
17,284
Total Accounts Receivable
35.00
31.00
299.00
185.00
3,320.00
3,189
Other Current Assets
27.00
84.00
77.00
345.00
705.00
1,904
Total Current Assets
625.00
1,066.00
6,449.00
30,644.00
23,906.00
22,500
Net Property, Plant & Equipment
5.00
3.00
5.00
3.00
18.00
26
Intangible Assets
18.00
14.00
10.00
6.00
4.00
16
Total Assets
648.00
1,083.00
6,464.00
30,653.00
23,928.00
22,542
ST Debt & Current Portion LT Debt
24.00
24.00
24.00
-
-
Accounts Payable
75.00
85.00
274.00
235.00
-
Other Current Liabilities
30.00
29.00
125.00
1,245.00
3,341.00
Total Current Liabilities
129.00
138.00
423.00
1,480.00
3,341.00
Long-Term Debt
46.00
1,267.00
-
3,239.00
3,511.00
Total Liabilities
175.00
1,405.00
423.00
4,719.00
6,852.00
Common Equity (Total)
473.00
322.00
6,041.00
25,934.00
17,076.00
Total Shareholders' Equity
473.00
322.00
6,041.00
25,934.00
17,076.00
Total Equity
473.00
322.00
6,041.00
25,934.00
17,076.00
Liabilities & Shareholders' Equity
648.00
1,083.00
6,464.00
30,653.00
23,928.00

About Diurnal Group

View Profile
Address
Cardiff Medicentre
Cardiff South Glamorgan CF14 4UJ
United Kingdom
Employees -
Website http://diurnal.co.uk
Updated 07/08/2019
Diurnal Group Plc is a specialty pharmaceutical company which addresses the unmet clinical and patient needs for hormone replacement treatments by creating products for life-long treatment for the chronic conditions, which include adrenal insufficiency, rheumatoid arthritis, hypogonadism and hypothryroidism. Its hormone therapeutics is used for proprietary formulations and novel physiological treatment regimes of approved drugs. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom.